Search research articles
Contact Us
Filters
Showing results (801-810 of 978) with videos related to
Page
of 98
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1994
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]
T Taguchi, H Furue, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1995
[A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)]
K Konishi, K Yabushita, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 1, 1983
[Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report]
O Abe, K Inokuchi, T Hattori, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
February 24, 2017
Risk stratification for congenital diaphragmatic hernia by factors within 24 h after birth
K Terui, K Nagata, Y Kanamori, et al.
Journal of Molecular Biology
|
January 22, 2008
Crystal structures of the Streptomyces coelicolor TetR-like protein ActR alone and in complex with actinorhodin or the actinorhodin biosynthetic precursor (S)-DNPA
A R Willems, K Tahlan, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 1987
[Oily chemoembolization of hepatoma]
H Nakamura, T Hashimoto, T Taguchi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
November 20, 2012
Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer
M Hata, T Taguchi, I Koike, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I study of recombinant human tumor necrosis factor
K Kimura, T Taguchi, I Urushizaki, et al.
Archives of Biochemistry and Biophysics
|
May 15, 1988
Biosynthesis of 20,20,20-trifluoroleukotriene B4 from 20,20,20-trifluoroarachidonic acid: a metabolically stable analog of leukotriene B4 and its application to a study of stimulation of leukotriene B4 synthesis by immunoglobulin G1,2
Y Tanaka, T M Klauck, W Jubiz, et al.
Oncology Reports
|
April 18, 1998
The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer
S J Kim, E Shiba, F Tsukamoto, et al.
Page
of 98
Search research articles
Search
Showing results (801-810 of 978) with videos related to
Sort By:
Page
of 98
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 1994
[Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug]
T Taguchi, H Furue, H Niitani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
June 1, 1995
[A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)]
K Konishi, K Yabushita, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
November 1, 1983
[Randomized study on the long-term adjuvant chemotherapy with ftorafur and mitomycin C for stomach cancer: second report]
O Abe, K Inokuchi, T Hattori, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
February 24, 2017
Risk stratification for congenital diaphragmatic hernia by factors within 24 h after birth
K Terui, K Nagata, Y Kanamori, et al.
Journal of Molecular Biology
|
January 22, 2008
Crystal structures of the Streptomyces coelicolor TetR-like protein ActR alone and in complex with actinorhodin or the actinorhodin biosynthetic precursor (S)-DNPA
A R Willems, K Tahlan, T Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 1987
[Oily chemoembolization of hepatoma]
H Nakamura, T Hashimoto, T Taguchi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
November 20, 2012
Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer
M Hata, T Taguchi, I Koike, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1987
Phase I study of recombinant human tumor necrosis factor
K Kimura, T Taguchi, I Urushizaki, et al.
Archives of Biochemistry and Biophysics
|
May 15, 1988
Biosynthesis of 20,20,20-trifluoroleukotriene B4 from 20,20,20-trifluoroarachidonic acid: a metabolically stable analog of leukotriene B4 and its application to a study of stimulation of leukotriene B4 synthesis by immunoglobulin G1,2
Y Tanaka, T M Klauck, W Jubiz, et al.
Oncology Reports
|
April 18, 1998
The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancer
S J Kim, E Shiba, F Tsukamoto, et al.
Page
of 98